Diabetes and Stem Cells: What Does the Future Hold?

00Days
00Hours
00Minutes
00Seconds

About the Case Presentation

The future of diabetes treatment may be revolutionized by stem cell research, offering hope for a long-term cure. Scientists are developing stem cell therapies that could regenerate insulin-producing beta cells in the pancreas, potentially restoring natural insulin production in people with type 1 diabetes. Early clinical trials have shown promising results, with some patients reducing or eliminating their need for insulin injections. While challenges like immune rejection and long-term efficacy remain, continued advancements suggest stem cell therapy could significantly change diabetes management in the coming years.

About the Speaker

Dr. Rohit Warrier

Senior Diabetes Specialist & physician Apollo & Apotek Healthcare, Global Teaching faculty, American Board of Regenerative Medicine

Dr. Rohit Warrier is an accomplished physician and educator specializing in diabetes care, regenerative medicine, and metabolic wellness. He currently serves as the Head of Clinical Operations at Twin Health, a pioneering diabetes remission company leveraging precision and personalized medicine through advanced technology. In addition, he is a Senior Diabetes Specialist at Apollo Clinic and a Consultant Diabetes Specialist formerly at Jothydev’s Diabetes Research Centre in Kochi. With nearly a decade of experience in medical education, Dr. Warrier is a global teaching faculty member with the American Board of Regenerative Medicine and an RTS-certified tutor for postgraduate medical training at the University of South Wales, UK. His academic credentials include certifications from the American Board of Regenerative Medicine (DABRM) and the European Board of Endocrinology, Diabetes & Metabolism (EBEEDM). A passionate stem cell researcher, Dr. Warrier’s expertise spans diabetes remission, clinical development, and metabolic health, making him a leader in the field of regenerative and lifestyle medicine.